Dr. Reddy's Laboratories ...

NYSE: RDY · Real-Time Price · USD
14.15
0.04 (0.28%)
At close: Aug 15, 2025, 9:51 AM

Dr. Reddy's Laboratories Balance Sheet Statement

Financials in INR. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
14.65B 7.11B 5.78B 14.85B 14.83B
Short-Term Investments
43.25B 74.36B 60.97B 29.51B 19.74B
Long-Term Investments
15.2B 5.25B 6.09B 7.99B 8.33B
Other Long-Term Assets
2.79B 16.12B 12.71B 948M 952M
Receivables
109.79B 80.3B 72.48B 66.76B 49.64B
Inventory
71.08B 63.55B 48.67B 50.88B 45.41B
Other Current Assets
4.56B 20.78B 19.85B 18.7B 17.48B
Total Current Assets
250.11B 248.05B 204.25B 181.11B 148.25B
Property-Plant & Equipment
97.76B 76.89B 56.54B 62.17B 57.11B
Goodwill & Intangibles
108.61B 41.2B 36.2B 31.66B 40.22B
Total Long-Term Assets
242.88B 139.47B 118.6B 115.55B 117.24B
Total Assets
492.99B 387.52B 322.85B 296.65B 265.49B
Account Payables
20.05B 21.55B 17.86B 15.97B 12.7B
Deferred Revenue
1.98B n/a 1.98B 2.58B 2.03B
Short-Term Debt
38.05B 12.72B 11.19B 27.08B 23.14B
Other Current Liabilities
13.52B 19.97B 16.95B 17.69B 14.88B
Total Current Liabilities
130.39B 96.04B 85.72B 97.84B 81.47B
Long-Term Debt
3.8B 3.8B n/a 3.8B 3.8B
Other Long-Term Liabilities
2.3B 4.94B 2.99B 2.54B 2.4B
Total Long-Term Liabilities
25.43B 10.93B 4.27B 8.29B 9.04B
Total Liabilities
155.82B 106.97B 89.99B 106.13B 90.51B
Total Debt
46.77B 20.02B 13.47B 33.84B 30.31B
Common Stock
834M 834M 833M 832M 832M
Retained Earnings
315.79B 265.26B 215.59B 175.71B 157.93B
Comprehensive Income
3.98B 4.03B 1.27B 1.06B 1.33B
Shareholders Equity
333.39B 280.55B 232.86B 190.53B 174.98B
Total Investments
58.46B 79.62B 67.06B 37.5B 28.08B